Latest Sales Performance News

BPH Global has secured a $1 million strategic placement to accelerate growth of its Indonesian seaweed trading operations, backed by record sales and robust infrastructure. This capital injection aims to boost trading volumes and pave the way for higher-margin revenue streams.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Freehill Mining Limited reported a robust 46% increase in quarterly sales, driven by strong demand at its Islon aggregate site and steady contributions from Yerbas Buenas. Meanwhile, the company advances promising copper and gold project assessments.

Holista Colltech has reported a positive operating cash flow for the December quarter, driven by disciplined cost management and a successful capital raise, despite softer sales and ongoing legal disputes.

Range International Limited has reported its strongest quarterly sales and production figures yet in Indonesia, while strategically pivoting towards a pallet rental model to secure more stable revenue streams.

BPH Global Ltd has recorded its second highest monthly seaweed sales since May 2025, driven by a strategic shift towards independent operations in Indonesia. The company’s aggregate sales now exceed A$2.15 million, underpinning its growth ambitions for 2026.

Botanix Pharmaceuticals reported a robust 28% increase in net revenue for Sofdra in Q2 FY26, driven by a 24% rise in prescriptions and a growing US sales team. The company maintains a strong cash position while navigating higher operating costs.

RooLife Group Ltd has reported a remarkable doubling of its coffee and food sales in China, surpassing A$2.1 million in December 2025 and signaling strong momentum in its data-driven e-commerce strategy.

ARB Corporation’s half-year results reveal a modest sales dip driven by Australian OEM challenges, while robust US export growth offers a silver lining.

Yancoal has reported record coal production and sales for 2025, achieving near the top of its guidance range with improved realised prices despite challenging market conditions. The company’s robust cash position and disciplined cost management position it well for future growth.

Jupiter Energy reported steady oil production and US$1.6 million in domestic sales for Q4 2025, while completing integration of its West Zhetybai oilfield into a regional gas utilisation network.

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.